180 related articles for article (PubMed ID: 21745565)
1. The driver of malignancy in KG-1a leukemic cells, FGFR1OP2-FGFR1, encodes an HSP90 addicted oncoprotein.
Jin Y; Zhen Y; Haugsten EM; Wiedlocha A
Cell Signal; 2011 Nov; 23(11):1758-66. PubMed ID: 21745565
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation.
Peiris MN; Meyer AN; Nelson KN; Bisom-Rapp EW; Donoghue DJ
Haematologica; 2020 May; 105(5):1262-1273. PubMed ID: 31439673
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery.
Miyata Y
Cell Mol Life Sci; 2009 Jun; 66(11-12):1840-9. PubMed ID: 19387550
[TBL] [Abstract][Full Text] [Related]
4. The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo.
Wendel T; Zhen Y; Suo Z; Bruheim S; Wiedlocha A
Exp Cell Res; 2016 Jan; 340(2):220-6. PubMed ID: 26748184
[TBL] [Abstract][Full Text] [Related]
5. Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells.
Gray PJ; Stevenson MA; Calderwood SK
Cancer Res; 2007 Dec; 67(24):11942-50. PubMed ID: 18089825
[TBL] [Abstract][Full Text] [Related]
6. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.
Ota A; Zhang J; Ping P; Han J; Wang Y
Circ Res; 2010 Apr; 106(8):1404-12. PubMed ID: 20299663
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.
Grand EK; Grand FH; Chase AJ; Ross FM; Corcoran MM; Oscier DG; Cross NC
Genes Chromosomes Cancer; 2004 May; 40(1):78-83. PubMed ID: 15034873
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
9. Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning.
Smith JR; Workman P
Cell Cycle; 2009 Feb; 8(3):362-72. PubMed ID: 19177013
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome.
Delaval B; Létard S; Lelièvre H; Chevrier V; Daviet L; Dubreuil P; Birnbaum D
Cancer Res; 2005 Aug; 65(16):7231-40. PubMed ID: 16103074
[TBL] [Abstract][Full Text] [Related]
11. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A
Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
[TBL] [Abstract][Full Text] [Related]
13. Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.
Erazo T; Moreno A; Ruiz-Babot G; Rodríguez-Asiain A; Morrice NA; Espadamala J; Bayascas JR; Gómez N; Lizcano JM
Mol Cell Biol; 2013 Apr; 33(8):1671-86. PubMed ID: 23428871
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 and Cdc37 -- a chaperone cancer conspiracy.
Pearl LH
Curr Opin Genet Dev; 2005 Feb; 15(1):55-61. PubMed ID: 15661534
[TBL] [Abstract][Full Text] [Related]
15. L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.
Moriwaki Y; Kim YJ; Ido Y; Misawa H; Kawashima K; Endo S; Takahashi R
Neurosci Res; 2008 May; 61(1):43-8. PubMed ID: 18359116
[TBL] [Abstract][Full Text] [Related]
16. Nuclear accumulation of fibroblast growth factor receptors in human glial cells--association with cell proliferation.
Stachowiak EK; Maher PA; Tucholski J; Mordechai E; Joy A; Moffett J; Coons S; Stachowiak MK
Oncogene; 1997 May; 14(18):2201-11. PubMed ID: 9174056
[TBL] [Abstract][Full Text] [Related]
17. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1.
Gaude H; Aznar N; Delay A; Bres A; Buchet-Poyau K; Caillat C; Vigouroux A; Rogon C; Woods A; Vanacker JM; Höhfeld J; Perret C; Meyer P; Billaud M; Forcet C
Oncogene; 2012 Mar; 31(12):1582-91. PubMed ID: 21860411
[TBL] [Abstract][Full Text] [Related]
18. A client-binding site of Cdc37.
Terasawa K; Minami Y
FEBS J; 2005 Sep; 272(18):4684-90. PubMed ID: 16156789
[TBL] [Abstract][Full Text] [Related]
19. Exposure of protein kinase motifs that trigger binding of Hsp90 and Cdc37.
Prince T; Matts RL
Biochem Biophys Res Commun; 2005 Dec; 338(3):1447-54. PubMed ID: 16269130
[TBL] [Abstract][Full Text] [Related]
20. Serine/Threonine Kinase Unc-51-like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (Cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins.
Li R; Yuan F; Fu W; Zhang L; Zhang N; Wang Y; Ma K; Li X; Wang L; Zhu WG; Zhao Y
J Biol Chem; 2017 Feb; 292(7):2830-2841. PubMed ID: 28073914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
